Aflac (AFL) Earnings Date & Reports
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan... Show more
AFL is expected to report earnings to rise 1.71% to $1.78 per share on August 06
Aflac Incorporated (AFL) First Quarter 2026 Earnings Recap: Japan Sales Surge 26%
Key Takeaways
- Aflac reported first quarter 2026 revenue of $4.35 billion, a 28% increase year-over-year, driven by higher investment gains.
- Adjusted earnings per share (EPS, a common profitability measure) came in at $1.75, up 5% from the prior year but slightly below consensus estimates of $1.80.
- Japan segment new annualized premium sales rose 26% to ¥17.7 billion, fueled by strong product launches like Anshin Palette and Miraito.
- U.S. sales increased 3% to $318 million, supported by growth in group voluntary benefits and life products.
- The company repurchased $1.0 billion in shares and raised its quarterly dividend by 5% to $0.61 per share.
- Pretax adjusted profit margin in Japan improved to 35%, up from 32% a year ago.
Earnings Context and Why It Matters
Aflac Incorporated, a leading provider of supplemental health and life insurance, operates primarily in Japan and the U.S. This first quarter 2026 report is crucial as it reflects the company's resilience amid currency headwinds from a weaker yen and variable investment returns. Investors watch closely for sales momentum in Japan, where new products drove growth, and steady U.S. expansion in group benefits. With shares repurchased aggressively and dividends hiked for the 43rd consecutive year, the results underscore Aflac's capital return strategy. In a competitive insurance landscape, these earnings signal operational execution and potential for profitable growth, influencing valuation amid interest rate shifts and economic uncertainty.
Aflac delivered first quarter 2026 total revenues of $4.346 billion, surging 27.9% from $3.398 billion in the prior year, largely due to net investment gains of $49 million compared to losses of $963 million last year. Net earnings reached $1.019 billion, or $1.98 per diluted share, versus $29 million, or $0.05 per share, a year ago.
However, on an adjusted basis excluding investment gains/losses, earnings were $901 million, down 0.6% year-over-year, with adjusted EPS of $1.75, up 5.4% from $1.66 but missing Wall Street's $1.80 consensus. Revenue exceeded expectations of around $4.32 billion.
In Japan, pretax adjusted earnings rose 8.3% in yen to ¥119 billion ($759 million), with new business sales up 25.5% despite a 1 percentage point drop in premium persistency to 92.8%. U.S. pretax adjusted earnings grew 1.4% to $363 million, with sales up 2.9% and persistency steady at 79.3%. Adjusted net investment income was $902 million, slightly below prior year.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research process.
Market Reaction and Investor Sentiment
Following the April 29 after-market release, Aflac shares traded lower in pre-market on April 30, dropping about 3.9% to $111.67 overnight, reflecting disappointment over the adjusted EPS miss despite the revenue beat. By market close on April 30, the stock recovered somewhat, ending at $116.21, down just 0.07% from the April 29 close of $116.29. Sentiment appears mixed, with praise for Japan sales growth and capital returns tempered by weaker investment income and currency impacts.
Forward Outlook and Key Factors to Monitor
Aflac emphasized continued focus on profitable growth through product innovation in Japan and the U.S., with no major changes to prior guidance. The company anticipates Japan's earned premiums to decline 1-2% for full-year 2026, while U.S. premiums target the lower end of 3-6% growth.
Investors should track Japan premium persistency, which dipped slightly this quarter, and new sales momentum from hits like Anshin Palette medical insurance. In the U.S., group voluntary benefits and dental/vision uptake remain key amid competitive pressures.
Investment portfolio performance is critical, as variable income fell short of expectations by $14 million. A weaker yen (average 156.87 vs. 152.40 prior year) pressured USD results, so currency trends will influence adjusted EPS. Ongoing share repurchases—$1.0 billion this quarter—and the 43-year dividend increase streak signal strong capital deployment, but rising interest expenses in corporate warrant attention.
Upcoming catalysts include the Q2 earnings in August and broader economic signals affecting supplemental insurance demand, such as healthcare costs and employment trends.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Advertisement
General Information
a provider of supplemental life and health insurance services
Industry LifeHealthInsurance